ADIPOQ and Insulin resistance: Although adiponectin has anti-inflammatory effects, its levels significantly decrease in obesity, increasing the risk of insulin resistance and inflammation, which further aggravates cognitive dysfunction and the risk of AD (Forny-Germano et al., 2018).